These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5917283)

  • 1. Clinical and epidemiological studies on hepatocerebral disease in Japan.
    Yoshikawa M; Mozai T; Hirai S
    Prog Brain Res; 1966; 21():269-84. PubMed ID: 5917283
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetical and epidemiological studies of Wilson's disease in Japan].
    Sano I; Arima M
    Seishin Shinkeigaku Zasshi; 1967 Jun; 69(6):555-62. PubMed ID: 5625390
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wilson's disease in Switzerland. Clinical, genetic and biochemical studies].
    Tschumi A; Colombo JP; Moser H
    Schweiz Med Wochenschr; 1973 Jan; 103(3):89-95. PubMed ID: 4683518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hepatocerebral dystrophy in the Bashkir ASSR].
    Magzhanov RV; Pertsev GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):346-9. PubMed ID: 6455023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on hepatocerebral disease. III. Hepatolenticular degeneration in Japan, with studies on copper metabolism.
    OKINAKA S
    Neurology; 1961 Sep; 11():792-9. PubMed ID: 13730604
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 7. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
    Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
    Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
    [No Abstract]   [Full Text] [Related]  

  • 8. Wilson's disease in Turkey, a review of 49 cases in 41 families.
    Aksoy M; Erdem S
    New Istanbul Contrib Clin Sci; 1975 Jun; 11(2):92-7. PubMed ID: 1107956
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 10. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiologic study of Wilson's disease in West Germany].
    Przuntek H; Hoffmann E
    Nervenarzt; 1987 Mar; 58(3):150-7. PubMed ID: 3495740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Wilson's disease in East Germany: in retrospect and perspectives -- an evaluation].
    Lössner J; Bachmann H; Siegemund R; Kühn HJ; Günther K
    Psychiatr Neurol Med Psychol (Leipz); 1990 Oct; 42(10):585-600. PubMed ID: 2077550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Wilson's disease--a long term follow-up.
    Arima M; Komiya K
    Paediatr Univ Tokyo; 1970 Dec; 18():22-4. PubMed ID: 5514643
    [No Abstract]   [Full Text] [Related]  

  • 15. Hudson memorial lecture: Wilson's disease: genetics and biochemistry--their relevance to therapy.
    Walshe JM
    J Inherit Metab Dis; 1983; 6 Suppl 1():51-8. PubMed ID: 6413775
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspects of cuprogenic disorder in Wilson's Disease in India.
    Dastur DK; Manghani DK
    Clin Exp Neurol; 1979; 16():1-8. PubMed ID: 550935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Wilson's disease. I].
    Sánchez Rodríquez A; González Macias J; Diez Jarilla JL; Suquia Múgica B; de Portugal Alvarez J
    Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):68-73. PubMed ID: 6753060
    [No Abstract]   [Full Text] [Related]  

  • 18. Disorders in Hepatic Copper Secretion: Wilson's Disease and Pleomorphic Syndromes.
    Lalioti V; Tsubota A; Sandoval IV
    Semin Liver Dis; 2017 May; 37(2):175-188. PubMed ID: 28564725
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on levels of penicillamine-induced cupriuresis in heterozygotes of Wilson's disease.
    Tu JB; Blackwell RQ
    Metabolism; 1967 Jun; 16(6):507-13. PubMed ID: 6028804
    [No Abstract]   [Full Text] [Related]  

  • 20. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.